EUVIMEDEUVIMED entdecken
Crossref

Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers

Yufei Wang, Guihua Wang, Wei Xiang, Xueting Liu, Manli Jiang, Jinyue Hu

European Journal of Pharmacology · 2024

DOI: 10.1016/j.ejphar.2024.176558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmacology, 2024. Verfasst von Yufei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Center, Affiliated Changsha Central Hospital of Hengyang Medical School, University of South China, Changsha, 410004, China. Hauptthemen laut MEDLINE: Polo-Like Kinase 1, Cell Cycle Proteins, Protein Serine-Threonine Kinases, Proto-Oncogene Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhibitors of polo-like kinase (PLK) are currently being evaluated as anticancer drugs. However, the molecular mechanism of PLK inhibitor-induced cell death is not fully understood. In this study, we found that GW843682X and BI2536, two inhibitors of PLK1, significantly induced cell death in multiple type cells. The induction of cell death was related to the preferring expression of PLK1. However, in human umbilical vascular endothelial cells (HUVEC) and human colorectal carcinoma cells, which expressed higher levels of both PLK1 and PLK2, PLK1 inhibitors induced very low levels of cell death. Clinical analysis reveals PLK1 presence in 26 of 30 NPC tumor tissues. In in vivo NPC lung metastasis nude mouse models, PLK1 inhibitors decreased NPC progress. Mechanistically, the PLK1 inhibitor did not activate p53, and the cell death was not reversed by p53 inhibition. Moreover, PLK1 inhibitor-induced cell death was PARP- and caspase-independent. Although PLK1 inhibitors induced down-regulation of calpain inhibitor calpastatin and calpain was activated by PLK1 inhibition, calpain blocking did not reverse cell death induced by PLK1 inhibitors, suggesting the non-involvement of calpain. Surprisingly, we found that PLK1 inhibitors induced the activation of proteasome, and the treatment of cells with PLK1 inhibitors reduced the levels of ubiquitinated proteins. And proteasome inhibitors reversed cell death induced by PLK1 inhibitors in various cell types in which PLK1 was preferentially expressed. Moreover, PLK1 inhibition reversed the degradation of proteins including p53, caspase 8, PARP and calpastatin. These results suggest that the activation of proteasome is critical for cell death induced by PLK1 inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polo-Like Kinase 1Cell Cycle ProteinsProtein Serine-Threonine KinasesProto-Oncogene ProteinsProteasome Endopeptidase ComplexCell DeathHumansAnimalsMiceCell Line, TumorProtein Kinase InhibitorsMice, NudePteridinesHuman Umbilical Vein Endothelial CellsCalpainEnzyme ActivationXenograft Model Antitumor AssaysTumor Suppressor Protein p53Antineoplastic Agents

Stichwörter der Autor:innen

BI2536CancerCell deathGW843682XPLK1Proteasome

Substanzen

Polo-Like Kinase 1Cell Cycle ProteinsProtein Serine-Threonine KinasesProto-Oncogene ProteinsProteasome Endopeptidase ComplexBI 2536Protein Kinase InhibitorsPteridinesCalpainTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Medical Research Center, Affiliated Changsha Central Hospital of Hengyang Medical School, University of South China, Changsha, 410004, China.
  • Department of Oncology, Affiliated Changsha Central Hospital of Hengyang Medical School, University of South China, Changsha, 410004, China.
  • Medical Research Center, Affiliated Changsha Central Hospital of Hengyang Medical School, University of South China, Changsha, 410004, China. Electronic address: 2018050703@usc.edu.cn.

Zitieren

APA

Wang, Y., Wang, G., Xiang, W., Liu, X., Jiang, M., & Hu, J. (2024). Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2024.176558

Vancouver

Wang Y, Wang G, Xiang W, Liu X, Jiang M, Hu J. Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers. European Journal of Pharmacology. 2024. doi:10.1016/j.ejphar.2024.176558

BibTeX
@article{Wang2024,
  author = {Wang, Yufei and Wang, Guihua and Xiang, Wei and Liu, Xueting and Jiang, Manli and Hu, Jinyue},
  title = {Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers},
  journal = {European Journal of Pharmacology},
  year = {2024},
  doi = {10.1016/j.ejphar.2024.176558}
}
Kostenlos starten →